MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GRONENBORN, A.
Right arrow Articles by BURGEN, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GRONENBORN, A.
Right arrow Articles by BURGEN, A.

Molecular Pharmacology, Vol 20, 145-153, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

1H and 31P NMR Characterization of Two Conformations of the Trimethoprim-NADP+-Dihydrofolate Reductase Complex

ANGELA GRONENBORN 1, BERRY BIRDSALL 1, EVA HYDE 1, GORDON ROBERTS 1, JAMES FEENEY 1, and ARNOLD BURGEN 1

1 Division of Molecular Pharmacology, National Institute for Medical Research, London NW7 1AA, England

The ternary complex between Lactobacillus casei dihydrofolate reductase, the coenzyme NADP+, and the antibacterial drug trimethoprim was studied by 1H and 31P NMR spectroscopy. The C2-H resonances of two of the histidine residues of the protein were each split into two signals of approximately half-proton intensity in the 1H spectrum of this complex. Studies of the temperature-dependence of the lineshape of these histidine signals showed that the splitting is due to the coexistence of approximately equal amounts of two slowly interconverting (6 sec-1 at 31°) conformational forms of the complex. Two sets of proton resonances from the bound coenzyme were identified by the use of selectively deuterated coenzyme and by transfer of saturation experiments. Conformation I was characterized by nicotinamide proton resonances shifted substantially (0.6-1.1 ppm) to low field from their positions in the free coenzyme, while in Conformation II the changes in chemical shift on binding were much smaller (le0.12 ppm). Only a single set of 1H resonances from the bound trimethoprim was observed in transfer of saturation experiments at 45°, perhaps because of relatively rapid interconversion between the two conformational states at this temperature. However, the addition of NADP+ produced a large (1.1 ppm) upfield shift of the 2',6'-proton resonance of trimethoprim relative to its position in the binary complex. In the 31P spectrum of the bound coenzyme, two sets of signals were seen for the pyrophosphate phosphorus nuclei. As judged from both the 1H and 31P spectra, the complexes of enzyme, trimethoprim, and NADP+ or NHDP+ (the hypoxanthine analogue) are mixtures of Conformations I and II, whereas the complexes formed with the thionicotinamide or acetylpyridine analogues of the coenzymes (TNADP+ and APADP+) are exclusively in Conformation II. The enzyme-methotrexate-NADP+ complex is exclusively in Conformation I. Comparing the 31P spectra of the enzyme-trimethoprim-TNADP+ and enzyme-methotrexate-NADP+ complexes, the two conformational states were found to differ in the conformation of the pyrophosphate backbone of the bound coenzyme, as indicated by the 31P-1H and 31P-31P spin-spin coupling constants. This system appears to be an example of a two-state conformational equilibrium which can be "switched" by the binding of ligands of different structure. The nature of the two conformational states and their implications for structure-activity analysis are discussed.

Note:
ACKNOWLEDGMENTS We are grateful to Gill Ostler and John McCormick for invaluable technical assistance, to Dr. David Matthews for sending us the atomic coordinates derived from his crystallographic work, and to the Oxford Enzyme Group, particularly Iain Campbell and Peter Stiles, for the opportunity to use their 470 MHz spectrometer.

Submitted on December 29, 1980
Accepted on February 12, 1981







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics